That is to say, in sites typical for prostate cancer metastasis such as pelvic lymph nodes, even a PSMA score of 1 (between the levels of the blood pool and liver) should be interpreted as positive [45, 46], while uptake in atypical sites for metastatic prostate cancer should be evaluated with caution. This evidence concerns the gene FOLH1 and prostate cancer.